BIC (BB) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 Apr, 2026Executive summary
Q1 2026 organic net sales grew by 1.6%, meeting expectations, with broad-based gains across categories and regions, except for declines in the Middle East and Africa due to ongoing conflict.
US performance improved, led by Stationery and Lighters, while Tangle Teezer delivered 13% organic growth with double-digit gains in North America and Europe.
Portfolio streamlined by exiting underperforming businesses, with new leadership fully operational and a strategic plan to be announced in September 2026.
Financial highlights
Q1 2026 net sales were €453m, up 1.6% organically year-over-year, but down 5.3% reported due to negative FX (-5.0%) and perimeter (-1.9%) impacts.
Stationery contributed €4m, lighters €3m, and Blade Excellence €1m to organic growth.
All divisions posted organic growth: Human Expression +3.0%, Flame for Life +1.7%, Blade Excellence +0.6%.
Latin America led regional organic growth at +5.3%; North America and Europe both grew +1.6% organically.
Volume declined by 1%, while price/mix was positive across all markets.
Outlook and guidance
2026 outlook remains unchanged: improving organic net sales trends, slight expansion in adjusted EBIT margin, and stable free cash flow year-over-year.
Cautious stance maintained due to ongoing volatility, especially in the Middle East.
Full strategy update to be presented in September; focus remains on delivering commitments and sustainable growth.
Latest events from BIC
- Resilient 2025 performance, strong cash flow, and renewed growth in Q1 2026.BB
Investor presentation3 May 2026 - Net sales fell 0.9% to €2,090m, but Tangle Teezer and cash flow guidance remain positive for 2026.BB
Q4 202525 Feb 2026 - 2024 sales hit €2.2bn, with strong margins, cash flow, and leadership in core categories.BB
Investor presentation24 Feb 2026 - Resilient margins and growth outside North America support 2024 outlook and cash flow.BB
Q2 20242 Feb 2026 - Q3 2024 saw robust margin gains and cash flow, with an upgraded EBIT margin outlook.BB
Q3 202418 Jan 2026 - Resilient 2024 results with strong margins and Tangle Teezer set to drive 2025 growth.BB
Q4 202428 Dec 2025 - Q1 2025 sales fell 8.3% as reported; 2025 outlook cut to 0–3% growth, 15% EBIT margin.BB
Q1 202526 Dec 2025 - Strong 2024 results, sustainability gains, and leadership transition set the stage for 2025.BB
AGM 202518 Nov 2025 - Q2 growth and Tangle Teezer gains offset H1 sales decline, with margins and outlook resilient.BB
Q2 20253 Nov 2025